CrossrefInfokarte
Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish · 2018
DOI: 10.1177/2284240318790951 ↗Abstract
Kein Abstract verfügbar.
EUVIMED